Hyaluronan Receptors

Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary THYMOCYTES; GRANULOCYTES; MACROPHAGES; erythrocytes, and fibroblasts. Their interaction with HYALURONIC ACID mediates binding of lymphocytes to high endothelial VENULES.

Also Known As:

CD44 Antigen; Chondroitin Sulfate Proteoglycan 8; Hyaluronan Receptor; Hyaluronic Acid Binding Protein; Antigen, CD44; Hyaluronan Binding Protein; Receptor, Hyaluronan; Antigens, CD44; CD44 Antigens; Hyaluronan-Binding Protein; Receptors, Hyaluronan

Carbohydrates: 22023
- Polysaccharides: 15383
  - Proteoglycans: 4798
    - Chondroitin Sulfate Proteoglycans: 569
      - Hyaluronan Receptors: 308
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Proteoglycans: 4798
      - Chondroitin Sulfate Proteoglycans: 569
        Hyaluronan Receptors: 308
    - Membrane Glycoproteins: 2252
      - Cell Adhesion Molecules: 4858
        Lymphocyte Homing Receptors: 25
        Hyaluronan Receptors: 308
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Proteoglycans: 4798
      - Chondroitin Sulfate Proteoglycans: 569
        Hyaluronan Receptors: 308
    - Membrane Glycoproteins: 2252
      - Cell Adhesion Molecules: 4858
        Lymphocyte Homing Receptors: 25
        Hyaluronan Receptors: 308
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Cell Adhesion Molecules: 4858
        Lymphocyte Homing Receptors: 25
        Hyaluronan Receptors: 308
    - Cell Surface Receptors: 2125
      - Immunologic Receptors: 9
        Lymphocyte Homing Receptors: 25
        Hyaluronan Receptors: 308
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Cell Adhesion Molecules: 4858
      - Lymphocyte Homing Receptors: 25
        Hyaluronan Receptors: 308

Silvana Breiteneder-Geleff Selected Research

Silvana Breiteneder-Geleff Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure